NCT02166463
Clinical Trial Information
Trial Number: NCT02166463 (ClinicalTrials.gov)
Disease Type:
- Hematopoietic Neoplasm/Lymphoma - Hodgkin Lymphoma
Trial Title:
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Study ID:
AHOD1331
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02166463-D1 | NCT02166463-D1: There is 1 dataset associated with the PMID 36322844: NCT02166463-D1. This dataset, NCT02166463-D1, provides the information for baseline characteristics and all analyses reported in the manuscript (Tables 1-2, Figures 1-3; Supplementary Appendix tables S1, 2b, S3-6 and Figures S1-S3). There is one row per patient. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®